+ All Categories
Home > Documents > Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for...

Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for...

Date post: 26-Jun-2018
Category:
Upload: vucong
View: 213 times
Download: 0 times
Share this document with a friend
19
Cell-free synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial Biotechnology Montréal, 24.07.2017
Transcript
Page 1: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Cell-free synthetic biology as key enabling

technology for novel food ingredients

Marc Struhalla, CEO c-LEcta GmbH

BIO World Congress of Industrial Biotechnology

Montréal, 24.07.2017

Page 2: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Company introduction

Page 3: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

At a glance

c-LEcta is one of the world’s leading industrial

biotechnology company located in Leipzig,

Germany

Our core technological competence is the

engineering of enzymes and microorganisms

We provide biotechnological process

innovation for valuable products for the food,

feed and pharma industry

24.07.2017

Company Introduction

│3

BioCube Leipzig

BIO-WCIB 2017 c-LEcta.com

Page 4: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Staff of 50+ highly qualified people.

Profitable operational business since 2014

State-of-the-art research & production facility

with about 2.300 m2 including a pilot-scale

production and scale-up infrastructure.

Established premium technology partner and

supplier of biotech products to the industry

Company Introduction

│4

At a glance

Fermentation suite c-LEcta

BIO-WCIB 2017 c-LEcta.com 24.07.2017

Page 5: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Company introduction

│5

c-LEcta’s technology platform

BIO-WCIB 2017 c-LEcta.com

Strain Engineering

Biodiversity

New enzymes and

microbial strains from

natural sources

Enzyme Engineering

Optimized enzymes

obtained by directed

evolution

Efficient microbial

productions strains

obtained by metabolic

engineering

Optimized production

processes for ingredients

and enzymes

Bioprocess

Development

24.07.2017

Page 6: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

│6

Company introduction

2 Product categories

Industrial

enzymes

…produced by enzymatic

synthesis or fermentation

+ Ingredients

& additives

For applications in pharma, feed & food

…used as processing aids

in industrial production

BIO-WCIB 2017 c-LEcta.com 24.07.2017

Page 7: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

│7

c-LEcta products in the market

Company introduction

BIO-WCIB 2017 c-LEcta.com

Acrylaway HighT

CalB immo Plus

DENARASE

Food Enzyme; Asparaginase. Reduces

acrylamide formation if food products

Immobilized lipase. Used in pharma &

in the processing of lipids and oils

Nuclease. Used in the production of

vaccines & biopharmaceuticals

BIOCATALYSTSCustomized enzymes for the synthesis

of chemical drugs

distribution partners

Undisclosed customers

24.07.2017

Page 8: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Cell-free, synthetic biology

Page 9: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Cell-free synthetic biology

│9

Cell-free synthetic biology

BIO-WCIB 2017 www.c-LEcta.com

Use of artificial, engineered enzymes for one-pot,

multi-enzyme biotransformations

Main contra arguments: Conversion costs are two high. Enzymes make

use of very costly cofactors or cosubstrates and are too expensive

Product formation rate per time with the enzyme

amount obtained from one liter of fermentation broth:

Product titers obtainable in efficient enzymatic

synthesis processes:

Enzyme cost contribution per kilo of product under

recycling of process engineered enzymes:

> 1,000 g/h/l

> 400 g/l

< 0.1 EUR / kg

24.07.2017

Page 10: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

│10

Two examples from c-LEcta work

BIO-WCIB 2017 www.c-LEcta.com

Cost impact of enzymes

120-fold

reduction

Cost impact of cofactor NAD+

25-fold

reduction

24.07.2017

Cell-free synthetic biology

Improvement of process economics through

enzyme engineering & process development

Page 11: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Enzyme cascade for glucosylation

│11

Sucrose-

Synthase

Glucosyl-

Transferase

UDP-Glucose

TARGET

COMPOUND

TARGET

COMPOUND

UDP

Fructose Sucrose

BIO-WCIB 2017 www.c-LEcta.com 24.07.2017

Cell-free synthetic biology

Page 12: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Enzyme cascade for glucosylation

│12

TARGET

COMPOUND

TARGET

COMPOUND

Sucrose

+ +

Net Reaction:

Targets for an efficient process:

High substrate & product concentration

As low as possible UDP concentration

Highly efficient enzymes (low enzyme costs)

Fructose

Targets for enzyme engineering:

Reduce substrate & product inhibition

Decrease Km-values for UDP

Increase specific activity of enzymes

BIO-WCIB 2017 www.c-LEcta.com 24.07.2017

Cell-free synthetic biology

UDP

Page 13: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Enzyme cascade for glucosylation

│13

UDP cost contribution:

Non-optimized system:

[UDP] 0.25 mM

[Product] 25 g/L

Price UDP 2,300 € / kg

Cost contribution UDP:

10.0 € / kg Product

BIO-WCIB 2017 www.c-LEcta.com 24.07.2017

Cell-free synthetic biology

Optimized system:

[UDP] 0.05 mM

[Product] 150 g/L

Price UDP 2,300 € / kg

Cost contribution UDP:

0.34 € / kg Product

Page 14: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Engineering of a Glucosyl-Transferase

│14

0

5

10

15

20

25

30

35

40

45

50

fold

im

pro

vem

ent

Variants

WT

4-mutations

5-mutations

BIO-WCIB 2017 www.c-LEcta.com 24.07.2017

Cell-free synthetic biology

Page 15: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Sugar phosphorylase cascade

│15

Sugar-

Phosphorylase

Sucrose-

Phosphorylase

(SP)

Glucose-1-

Phosphate

TARGET

DISACCHARIDE

(Glc-Glc)

Fruktose

Glucose

Sucrose

+

Glucose-

Isomerase

Pi +

BIO-WCIB 2017 www.c-LEcta.com 24.07.2017

Cell-free synthetic biology

DISACCHARIDE

PRODUCTNet Reaction:

Sucrose

Pi

Page 16: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

0

0.02

0.04

0.06

0.08

0.1

250 500 750

init

ial a

cti

vit

iy[s

yn

the

sis

un

its

]

substrate concentration [mM]

Engineering of a cellobiose phosphorylase (CP)

Below

detection limit

G1P cellobiose + PiCP

glucose

| 16BIO-WCIB 2017 www.c-LEcta.com 24.07.2017

Cell-free synthetic biology

Page 17: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

0

5

10

15

20

25

30

35

fold

im

pro

ve

me

nt

250 mM substrate

500 mM substrate

750 mM substrate

Cellobiose phosphorylase engineering

1st gen to

stabilize backbone

WO2016038141

| 17BIO-WCIB 2017 www.c-LEcta.com 24.07.2017

Cell-free synthetic biology

Page 18: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

0

5

10

15

20

25

30

35

fold

im

pro

ve

me

nt

250 mM substrate

500 mM substrate

750 mM substrate

1st gen to

stabilize backbone

WO2016038141

| 18

Cellobiose phosphorylase engineering

BIO-WCIB 2017 www.c-LEcta.com 24.07.2017

Cell-free synthetic biology

Very low enzyme cost contribution

Process is economically viable

Synthesis process has been established & scaled-up by partner

Page 19: Cell-free synthetic biology as key enabling … synthetic biology as key enabling technology for novel food ingredients Marc Struhalla, CEO c-LEcta GmbH BIO World Congress of Industrial

Contact details

Marc StruhallaCEO

c-LEcta GmbH

Perlickstraße 5, 04103 Leipzig, Germany

Phone +49 341 / 355 214-0

[email protected]

www.c-LEcta.com


Recommended